Kyushu University's Qu Ventures has supported a series A round for robot-equipped consumer goods delivery service Starship Technologies.
Osage University Partners is among the series B investors backing Virginia Tech-linked IBD therapy disease developer Landos Biopharma, which is preparing phase 2 trials.
The spinout has revealed it added approximately $6m to a series A round backed by University of Pennsylvania and IP Group last year, bringing its total size to about $59m.
Allied Minds has returned again for a series B round that took the firm's geospatial data analytics technology subsidiary's total funding to about $96m.
Novo, Partners Healthcare and Sham all contributed to a $74.6m round for Alizé Pharma 3, which is exploiting research from three US institutions.
UTokyo IPC, Keio Innovation Initiative and Innovations and Future Creation have contributed to a $79.7m series A that increased the Tokyo spinout's total funding to about $100m.